The American specialist was granted the award as part of the city’s programme marking World TB Day on March 24.
Dr Nahid is an Associate Professor in the Division of PulmonaryCritical Care Medicine at the University of California, San Francisco(UCSF) in the US. He also serves as Director of the Chest and High RiskAsthma Clinic and is an attending physician for the PulmonaryConsultation Service and the Intensive Care Units at San FranciscoGeneral Hospital.
The doctor has spent yearsdesigning a network of TB clinical trials between the Hanoi Hospital ofLung Disease (HHLD), seven medical centres and TB control teams in localdistricts and communes.
The HHLD and TB control teams have been provided advanced medical equipment at a total fund of 300,000 USD.
According to Dr Nahid, the UCSF and the University of California (UCBerkley) have been conducting major field studies in TB control inVietnam, in partnership with the National TB Control Programme, theVietnam National Lung Hospital, the HHLD, the Vietnam National Instituteof Hygiene and Epidemiology (NIHE) and the Hanoi Department of Health.
In 2015, the third phase of clinical trials in TBtherapeutics will be undertaken to re-assess TB treatment guidelines,enabling a reduced duration for TB treatment, Nahid said.
Two experts from UC Berkley will also experiment with new TB detectionpractices using iPad-enabled microscope cameras in far-flung areas.
Meanwhile, the University of Stanford has worked with the NIHE toemploy new molecular biology testing for TB diagnosis and surveillance,instead of traditional forms of testing. The results of the new methodwill be evaluated this year, he added.
Dr Nahidrevealed that tuberculosis is the world’s top killer. As many as 52passenger aircrafts could be filled with patients who die of the diseaseevery year.
TB is the second leading cause ofmortality in people with infectious diseases in Vietnam, where more than100,000 new TB patients and 17,000 deaths are recorded every year.-VNA